HHS to Continue 340B “Orphan” Drug Rule
In July 2013 the U.S. Department of Health and Human Services (HHS)issued a final regulation allowing 340B covered entities (public safety-net health providers) to purchase orphan drugs at the discounted 340B prices even when the drugs aren’t used to treat […]